Global markets • Credit investing • AI infrastructure
Connecting macro trends, capital flows, and market structure through institutional-style research
I share high-return stock investment opportunities daily; daily trading strategies and market insights:
👉https://t.co/lfvIbA1dT4
The key to short-term trading is timing
By the time you receive a notification about X, the market may have already changed
Seize market opportunities
$LHKW $KIDZ $ZCMD $SBEV $AXTX
#NASDAQ#MicrocapStocks#StocksWorthWatching
$IBM 👀
🔹 Recently joined OpenAI's Daybreak Cybersecurity Partner Program
🔹 Further expands the convergence of enterprise AI and cybersecurity
🔹 OpenAI models can be embedded directly into security workflows to help identify vulnerabilities faster
As cyber threats increasingly operate at machine speed, defense systems may need to do the same ⚡
Neutral bullish📈
$ACCL range-bound action looks ready to break
Support at $1.58, resistance at $1.80–$1.98
$WOK $NVVE $AEHL — these could explode any time. Watch closely
$CLRO ClearOne announces merger deal with Cortigent (Vivani Medical subsidiary). $4.25 is the major resistance level. Breakout above it should unlock significant upside
$CLRO ClearOne announces merger deal with Cortigent (Vivani Medical subsidiary). $4.25 is the major resistance level. Breakout above it should unlock significant upside
$ATLN
Breaking News: Circle8 has won a $175 million extension to its contract with Dutch infrastructure management agency Rijkswaterstaat, bringing the total contract value to $432 million
Volatility in $ASTS is structural, not accidental
Large moves up followed by sharp retracements are part of the price discovery process in early-stage space infrastructure plays
$VTGN 🚀
PALISADE-4 top-line data expected anytime 👀
Fasedienol targets Social Anxiety Disorder, a huge unmet market
FDA Fast Track in place — data could be a major catalyst
$VTGN biotech catalyst alert 🧬
PALISADE-4 topline results for fasedienol are expected this month
If the data is positive, this could quickly become one of the most watched mental health biotech names
$KNDI update: stock near $0.60. With $220M cash and $9.15M quarterly burn, runway is ~72 months
Company enters backup power & storage for AI data centers
$LULU is showing early signs of a potential reversal 📍
Price is stabilizing near key support after a sustained downtrend inside a clear channel.
➡️ Selling pressure is easing
➡️ Momentum is starting to compress
➡️ Base formation may be developing
Key levels:
• 104–110 support zone holding
• 120 first resistance
• 130+ breakout confirmation
If support continues to hold and resistance breaks, a recovery phase could follow 🚀
$FDX bounced cleanly off its trendline and 50-day moving average after delivering a strong earnings report.
📦 EPS: $6.31 vs. $5.96 expected
📦 Revenue: $25.0B vs. $24.04B expected
The technical setup remains constructive, and if momentum continues, the next key target appears to be around $345.
📈👀
Volatility in $ASTS is structural, not accidental
Large moves up followed by sharp retracements are part of the price discovery process in early-stage space infrastructure plays
$VKTX is moving out of a long consolidation structure. 🚀
The breakout from the symmetrical triangle could mark a shift in trend behavior
Watching for continuation. 📈👀
$SKYQ ⛽🔥
The narrative is gaining traction
📍 Foreland Refinery has entered production
📍 Nevada's only active refinery
📍 Western fuel markets continue to face capacity constraints
As refining assets become increasingly scarce, traders and investors are paying closer attention to names with operational infrastructure already in place
Worth watching 👀📈